ALMR

Alamar Biosciences, Inc. NASDAQ Listed Apr 17, 2026

Healthcare ·Biotechnology ·US · alamarbio.com

$25.36

+1.16% vs $25.07

Mkt Cap $237.8M

52w Low $18.85 61.5% of range 52w High $29.43

50d MA $23.51 200d MA $23.54

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) 40.40

ATR (14) $1.87

Beta 0.00

50d MA $23.51

200d MA $23.54

Avg Volume 362.5K

Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.

SIC Code

3826

CIK (SEC)

2104204

Phone

(510) 626-9888

47071 Bayside Parkway · Fremont, CA 94538 · US

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 12	BofA Securities	Initiates	Neutral	$27	$23.88	$23.92	+0.2%	-3.8%	+0.2%	-2.2%	-4.3%	-3.2%
May 12	JP Morgan	Initiates	Overweight	$30	$23.88	$23.92	+0.2%	-3.8%	+0.2%	-2.2%	-4.3%	-3.2%
May 12	Leerink Partners	Initiates	Outperform	$35	$23.88	$23.92	+0.2%	-3.8%	+0.2%	-2.2%	-4.3%	-3.2%
May 12	Stifel	Initiates	Buy	$28	$23.88	$23.92	+0.2%	-3.8%	+0.2%	-2.2%	-4.3%	-3.2%
May 12	TD Cowen	Initiates	Buy	$30	$23.88	$23.92	+0.2%	-3.8%	+0.2%	-2.2%	-4.3%	-3.2%

Institutional (13F) — Top 0 All ↗

No 13F holders found.

Mutual Funds / ETFs (N-PORT) — Top 3 All ↗

#	Fund	Shares	Value	Period
1	Select Health Care Portfolio	300,000	$6M	May 2026
2	Select Medical Technology and Devices Portfolio	280,000	$6M	May 2026
3	Goldman Sachs Small Cap Growth Fund	38,564	$788K	May 2026

Data updated apr 24, 2026 5:24pm · Source: financialmodelingprep.com